Results 161 to 170 of about 123,362 (289)

B-type natriuretic peptide changes and left ventricular remodeling dynamics in heart failure with reduced ejection fraction. [PDF]

Front Cardiovasc Med
Romero E, Kushnir Y, Shahzad A, Patel DJ, Heejung B, Sirish P, Chiamvimonvat N, Liem DA, Cadeiras M.   +8 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Clinical application research of brain natriuretic peptide in patients with aneurysmal subarachnoid hemorrhage. [PDF]

Medicine (Baltimore)
Guo A, Ye C, Li J, Cao W.
europepmc   +1 more source

Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation. [PDF]

Eur Heart J Open
Salerno N, Leo I, Canino G, Bellantoni A, Di Costanzo A, Comito F, Mazza GA, Panuccio G, Giordano S, De Rosa S, Torella D, Sorrentino S.   +11 more
europepmc   +1 more source

The role and clinical value of natriuretic peptide receptor family in malignant tumor. [PDF]

Cell Death Discov
Quan C, Shao W, Yang Y, Yao Q, Yang Z, Yao Z.   +5 more
europepmc   +1 more source

Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.

, 1988
Dale C. Leitman, J W Andresen, Rosanne Catalano, Scott A. Waldman, J J Tuan, Ferid Murad   +5 more
openalex   +1 more source

Correction: Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting [PDF]

, 2011
Gregor Prosen, Petra Klemen, Matej Strnad, Štefek Grmec   +3 more
openalex   +1 more source

Molecular imprinting for neurology: Materials, applications, and limitations

Ibrain, EarlyView.
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma, Yingqi Ma, Claudia Marino, Alessandro Poma   +3 more
wiley   +1 more source

B-Type Natriuretic Peptide as a Marker of Subclinical Heart Disease in a High-Burden Emergency Department Population With Sustained Asymptomatic Hypertension. [PDF]

Int J Hypertens
Souffront K, Nelson BP, Lukas M, Garay HR, Shubeck C, Gordon L, Loo GT, Degtyar A, Wilder M, Iddrisu H, Coleman B, Richardson LD.   +11 more
europepmc   +1 more source

Effects of Natriuretic Peptides on the Centrally Mediated Pressor Response to Clonidine in Freely Moving Rats

, 1991
Shigeru Nakamura, Hiromu Kawasaki, Koichiro Takasaki   +2 more
openalex   +1 more source